Who owns NOVABAY PHARMACEUTICALS INC?
- Ticker: NBY
- CUSIP Number: 66987p409
Tip: Access positions for across all investors
Analyze quarterly positions in Novabay Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Novabay Pharmaceuticals stock
Who bought or sold NOVABAY PHARMACEUTICALS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Vanguard Group | 1.8M | $10M | 2065% | Dec 2025 |
|
| State Street Corporation | 314k | $1.8M | 971% | Dec 2025 |
|
| Northern Trust | 274k | $1.5M | 100% | Dec 2025 |
|
| Charles Schwab Investment Management | 93k | $526k | 100% | Dec 2025 |
|
| Susquehanna International | 47k | $264k | 100% | Dec 2025 |
|
| Qube Research & Technologies | 41k | $230k | 100% | Dec 2025 |
|
| Atomi Financial Group | 17k | $95k | 100% | Dec 2025 |
|
| Victory Capital Management | 14k | $81k | 100% | Dec 2025 |
|
| Tower Research Capital | 3.0k | $17k | 215% | Dec 2025 |
|
Who sold out of Novabay Pharmaceuticals?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| BlackRock | Dec 2025 | 1.8M | $10M |
| Geode Capital Management | Dec 2025 | 1.3M | $7.1M |
| Goldman Sachs Group | Dec 2025 | 104k | $589k |
| Jane Street | Dec 2025 | 70k | $395k |
| C2C Wealth Management | Dec 2025 | 45k | $254k |
| UBS Group | Dec 2025 | 34k | $190k |
| Apollon Wealth Management | Dec 2025 | 28k | $155k |
| Bank of New York Mellon | Dec 2025 | 26k | $146k |
| OMERS Administration Corporation | Dec 2025 | 21k | $120k |
| Morgan Stanley | Dec 2025 | 21k | $116k |
| ExodusPoint Capital Management | Dec 2025 | 20k | $114k |
| Virtu Financial | Sep 2025 | 11k | $14k |